Related Experiment Videos
Mutations in conserved regions 1, 2, and 3 of Raf-1 that activate transforming activity
Edmond Y W Chan1, Stacey L Stang, Drell A Bottorff
1Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.
Abstract:
To investigate the role of Raf-1 in v-Ha-ras transformation, we have isolated and characterized a number of Raf-1 mutants that display increased transforming activity in Rat2 fibroblasts. A dipeptide deletion (Delta144-145) in the cysteine-rich domain (CRD) of conserved region (CR) 1 increased the interaction between Raf-1 and v-Ha-ras effector loop mutants in the yeast two-hybrid system, supporting the proposal that the CRD serves as a secondary ras-binding domain. Many activating mutations were located in CR2. Two representative CR2 mutants (Delta250-258 and S257L) displayed increased interaction with v-Ha-ras effector loop mutants and with mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK) 1 in the two-hybrid system. One novel mutation in CR3 was recovered; G361S affected the third glycine of the GXGXXG protein kinase motif involved in ATP binding. Expression of G361S Raf-1 in Rat2 fibroblasts activated MEK and ERK. The CR1, CR2, and CR3 activating mutations, when combined in cis, cooperated in transforming Rat2 fibroblasts. Conversely, Raf-1 transforming activity was decreased when the S257L or G361S mutation was combined in cis with the R89E substitution, which disrupts ras-Raf interaction. This mutant analysis provides additional information about the distinct functions of individual Raf-1 regions and documents a novel genetic mechanism for activating an oncogenic kinase.
Insights
Researchers explored Raf-1 mutations in v-Ha-ras transformation, identifying key changes in conserved regions that enhance oncogenic kinase activity and fibroblast transformation. These findings reveal novel genetic mechanisms for activating oncogenic kinases.
Area of Science:
- Molecular Biology
- Oncology
- Cell Signaling
Background:
- Raf-1 is a key kinase in the Ras/Raf/MEK/ERK signaling pathway.
- v-Ha-ras transformation involves aberrant activation of this pathway.
- Understanding Raf-1's role is crucial for cancer research.
Purpose of the Study:
- To investigate the function of Raf-1 in v-Ha-ras-mediated cell transformation.
- To characterize novel Raf-1 mutants with enhanced transforming activity.
- To elucidate the distinct roles of different Raf-1 regions.
Main Methods:
- Isolation and characterization of Raf-1 mutants.
- Yeast two-hybrid system to assess protein interactions.
- Expression of Raf-1 mutants in Rat2 fibroblasts.
- Assays for mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK) and ERK activation.
Main Results:
- A deletion in the cysteine-rich domain (CRD) of conserved region 1 (CR1) increased Raf-1 interaction with Ras.
- Mutations in conserved region 2 (CR2) enhanced interactions with Ras and MEK1.
- A novel mutation in conserved region 3 (CR3) activated MEK and ERK.
- Combinations of activating mutations cooperated in fibroblast transformation.
Conclusions:
- The cysteine-rich domain of Raf-1 acts as a secondary Ras-binding domain.
- Distinct functional regions within Raf-1 contribute to oncogenic activity.
- Activating mutations in Raf-1 can cooperate to drive cellular transformation.
- This study reveals a novel genetic mechanism for oncogenic kinase activation.